A large quantity of coenzyme Q
10 (CoQ
10) naturally exists in mitochondria of various tissue cells in human beings, and has indispensable functions in the bioenergetics of cells. Some clinical reports have demonstrated that oral administration of CoQ to patients with periodontal disease is significantly effective in some cases. However, basic studies on the relationship between CoQ
10 and periodontal disease have not yet been done. The purpose of this study was to investigate the effect of oral administration of CoQ
10 on experimental periodontitis in dogs, particularly on the changes in CoQ-dependent enzymes.
Thirty adult dogs were divided into four groups: 1, normal group; 2, CoQ
10-treated normal group; 3, experimental periodontitis group; and 4, CoQ
10-treated experimental periodontitis group. The experimental periodontitis was induced by placing a cotton-floss ligature subgingivally around the crown of a molar tooth. CoQ
10 was administrated orally in a dose of 1.5 mg/kg daily for 2 weeks from the 3rd to the 4th week after the beginning of the experiment. The clinical estimations were performed by using gingival index, plaque index, and pocket depth. The CoQ10 levels in plasma and gingiva were determined by high performance liquid chromatography. The activities of CoQ-dependent enzymes, such as succinate dehydrogenase-CoQ reductase (SD-CoQR), succinic-cytochrome c reductase (S-CCR), and NADH-cytochrome c reductase (NADH-CCR) in the mitochondrial fraction of gingiva were determined in an enzyme assay system in which exogenous CoQ
3 was absent and present.
The results obtained can be summarized as follows:
1. The activity of CoQ
10-dependent enzymes such as SD-CoQR, S-CCR, and NADH-CCR were apparently present in the dog gingiva.
2. The oral administration of CoQ
10 to the normal group did not alter either the activity of CoQ-dependent enzymes or the level of CoQ
10 in gingiva, but tended to elevate the level of CoQ
10 in plasma.
3. Both the S-CCR and NADH-CCR activity in experimental periodontitis were significantly higher than in normal group. The CoQ-% deficiency of the S-CCR in the periodontitis group was increased considerably. No significant change was found in the CoQ
10 levels in plasma and gingiva of the periodontitis group.
4. The oral administration of CoQ
10 to be periodontitis group was effective in suppressing advanced gingival inflammation. The CoQ
10 levels in plasma and gingiva of the periodontitis group were significantly elevated by treatment with CoQ
10. The administration of CoQ
10 enhanced the activities of CoQ-dependent enzymes, and restored the increased CoQ-% deficiency of S-CCR to normal level.
View full abstract